Oral Abstracts
OA 17.02 Updated Efficacy Results From the BIRCH Study: First-Line Atezolizumab Therapy in PD-L1–Selected Patients With Advanced NSCLC

https://doi.org/10.1016/j.jtho.2017.09.428Get rights and content
Under an Elsevier user license
open archive

Cited by (0)